Solitary embolic cutaneous aspergillosis in the immunocompromised patients with acute myelogenous leukemia - A propos another cased caused by Aspergillus flavus

International Journal of Dermatology

Volumn 42, Issue 12, 2003, Pages 946-950

  Krunic, Aleksandar L ^a   Medenica, Maria ^a   Busbey, Shail ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; ARABINOSIDE; AZITHROMYCIN; CEFTAZIDIME; CYTOSINE; MITOXANTRONE; TOBRAMYCIN; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ASPERGILLOSIS; ASPERGILLUS FLAVUS; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CANCER INVASION; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; DERMATOMYCOSIS; DISEASE COURSE; DRUG FEVER; FEVER; FUNGUS HYPHAE; GENERAL CONDITION DETERIORATION; GRANULOCYTE TRANSFUSION; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNE DEFICIENCY; INFLAMMATION; INFLAMMATORY INFILTRATE; KIDNEY FAILURE; LUNG CONGESTION; LUNG NODULE; MALE; MINIMAL RESIDUAL DISEASE; NEUTROPENIA; NONHUMAN; PNEUMONIA; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; SEPSIS; SKIN BIOPSY; STAINING; THROMBOCYTOPENIA; TISSUE CULTURE; TREATMENT FAILURE;

AGED; ASPERGILLOSIS; ASPERGILLUS FLAVUS; DIAGNOSIS, DIFFERENTIAL; FACIAL DERMATOSES; FATAL OUTCOME; FUNGEMIA; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, MYELOCYTIC, ACUTE; MALE;

EID: 0347533900     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2003.01807.x     Document Type: Article

References (27)

1. Isaac M. Cutaneous aspergillosis. Dermatol Clin 1996; 1: 137-140.
2. VanBurik J-AH, Colven R, Spach DH. Cutaneous aspergillosis. Minireview. J Clin Microbiol 1998; 36: 3115-3121.
3. D'Antonio D, Pagano L, Girmenia Parruti G, et al. Cutaneous aspergillosis in patients with hematological malignancies. Eur J Clin Microbiol Infect Dis 2000; 19: 362-365.
4. Findley GH, Roux HF, Simson IW. Skin manifestations in disseminated aspergillosis. Br J Dermatol 1971; 85 (Suppl. 7): 94-97.
5. Bennet J. Aspergillus species. In: Mandell G, Bennet J, Dolin R, eds. Principles and Practice of Infectious Diseases, 4th edn, Vol. 2. New York: Churchill Livingstone 1995, 2306.
6. Skaria AM, Chavaz P, Hauser C. Metastatic aspergillus panniculitis in the case of blastic transformation of a myelodysplastic syndrome and agranulocytosis. Hautarzt 1995; 46: 579-581.
7. Fukuda M, Tominaga K, Endo K, Ito Y, Bessho M. Two cases of hematological malignancies diagnosed before death as aspergillosis with skin lesion. J Jpn Assoc Infect Dis 1998; 72: 543-547.
8. Galimberti R, Kowalczuk A, Hidalgo Parra I, Gonzalez Ramos M, Flores V. Cutaneous aspergillosis: A report of six cases. Br J Dermatol 1998; 139: 522-526.
9. Grossman ME, Fithian EC, Behrens C, Bissinger J, Fracaro M, Neu HC. Primary cutaneous aspergillosis in six leukemic children. J Am Acad Dermatol 1985; 12: 313-318.
10. Harmon CB, Su WP, Peters MC. Cutaneous aspergillosis complicating pyoderma gangrenosum. J Am Acad Dermatol 1993; 29: 656-658.
11. Weingarten JS, Crockett MD, Lusk RP. Fulminant aspergillosis: Early cutaneous manifestations and the disease process in the immunocompromised host. Otolaryngol Head Neck Surg 1987; 97: 495-499.
12. Vedder JS, Schorr WF. Primary disseminated pulmonary aspergillosis with metastatic skin nodules. J Am Med Assoc 1969; 209: 1191-1195.
13. Prystowsky SD, Vogelstein B, Ettinger DS, et al. Invasive aspergillosis. N Engl J Med 1976; 295: 655-658.
14. Rinaldi MG. Invasive aspergillosis. Rev Infect Dis 1983; 5: 1061-1077.
15. Verweij PE, Meis JFGM. Microbiological diagnosis of invasive fungal infections in transplant recipients. Transpl Infect Dis 2000; 2: 80-87.
16. Duthie R, Denning DW. Aspergillus fungemia. Report of two cases and review. Clin Infect Dis 1995; 20: 598-605.
17. Buchheidt D, Skladny H, Baust C, Hehlmann R. Systemic infections with Candida sp. and Aspergillus sp. in immunocompromised patients with hematological malignancies: Current serological and molecular diagnostic methods. Chemotherapy 2000; 46: 219-228.
18. Hunt SJ, Nagi C, Gross KG, Matthews WC. Primary cutaneous aspergillosis near central venous catheters in patients with the acquired immunodeficiency syndrome. Arch Dermatol 1992; 128: 1229-1232.
19. Pfaller MA, Messer SA, Hollis RJ, Jones RN. Antifungal activites of posaconazole, ravuconazole and amphotericin B against 239 clinical isolates of Aspergillus species and other filamentous fungi: Report from Sentry Antimicrobial Surveillance Program, 2000. Antimicrob Agent Chemother 2002; 46: 1032-1037.
20. Kuijer PHMM, Kuijper EJ, Van Den Tweel JG, Van Der Lelie J. Aspergillus fumigatus, a rare cause of fatal coronary artery occlusion. Infection 1992; 20: 45-47.
21. Pedailles S, Koenig S, Leporrier M. Localisation cutanees d'une aspergillose disseminee. A propos d'une observation. Ann Dermatol Venereol 1987; 114: 1549-1553.
22. Watsky KL, Eisen RN, Bolognia JL. Unilateral cutaneous emboli of Aspergillus. Arch Dermatol 1990; 126: 1214-1217.
23. Nenoff P, Kliem C, Mittag M, Horn LC, Niederwieser D, Haustein UF. Secondary cutaneous aspergillosis due to Aspergillus flavus in an acute myeloid leukemia patient following stem cell transplantation. Eur J Dermatol 2002; 12: 93-98.
24. Zimmerman LE. Fatal fungus infections complicating other diseases. Am J Clin Pathol 1955; 25: 46-65.
25. Coulot P, Bouchara JP, Renier G, et al. Specific interaction of Aspergillus fumigatus with fibrinogen and its role in cell adhesion. Infect Immun 1994; 62: 2169-2177.
26. Brown RL, Chen ZY, Cleveland TE, Cotty PJ, Cary JW. Variation in in vitro alpha-amylase and protease activity is related to the virulence of Aspergillus flavus isolates. J Food Protect 2001; 64: 401-404.
27. Tomee JF, Kauffman HF. Putative virulence factors of Aspergillus fumigatus. Clin Exp Allergy 2000; 30: 476-484.